Biopreservation Market: Current Analysis and Forecast (2021-2027)

Biopreservation Market: Current Analysis and Forecast (2021-2027)

  • UnivDatos Market Insight
  • August 2021
  • Healthcare
  • 182 pages

Report Description

Technological evolutions in the field of bio preservation processes paired with growing healthcare expenditure are predicted to improve the access towards quality healthcare and advanced products, which include biopreservation services, thus expanding growth possibilities. Also, the hospitals, gene banks, and biobanks, which are prominent end-users, are encouraging manufacturers to build technologically advanced biopreservation products to augment patient outcomes. For instance, 2021, Thermo Scientific launched Cytomat 24 automated incubators and storage systems to bring the latest incubation technology to large capacity microplate incubation applications, with excellent temperature uniformity and stability that ensure reproducibility for cell culture applications. The systems provide speedy delivery of microtiter plates through an advanced plate shuttle system to meet the needs of high-throughput laboratories and accelerate research. Further, the growing demand for personalized medicine will also boost the biopreservation market in the forecast period. Moreover, some factors that are expected to hinder the growth of this market involve the high cost of biopreservation equipment’s, lack of awareness among people about bio preservation, and constant concerns of people regarding tissue and cell injury during freezing and thawing will hinder the growth of biopreservation market in the forecast period.

During the Covid-19 pandemic, the bio preservation market has experienced a positive impact. With increasing cases of Covid-19, there was a huge need for the collection and preservation of Covid-19 samples. For instance, according to an article published by Mary Ann Liebert Inc. in December 2020, stated that some biobanks were instructed to put their activities in maintenance mode, to convert their operations to collection and testing facilities, or to rapidly realign themselves to allow the collection, processing, and storing of Covid-19 samples for their organizations. Many different Covid-19 initiatives have also been launched with the participation of government, academic, and industrial researchers. Moreover, there are many biobanks present worldwide that are collecting Covid-19 samples and data to be used by researchers. 

Telemedicine is the delivery of health care services, where  distance is a critical factor, by all health care professionals  using information and communications technologies for  the exchange of valid information for the diagnosis, treatment  and prevention of disease and injuries, research and  evaluation, and for the continuing education of health care providers, all in the interests of advancing the health of individuals and their communities.”

Telemedicine is the delivery of health care services, where distance is a critical factor, by all health care professionals using information and communications technologies for the exchange of valid information for diagnosis, treatment and prevention of disease and injuries, research and evaluation, and for the continuing education of health care providers, all in the interests of advancing the health of individuals and their communities.”

Telemedicine is the delivery of health care services, where distance is a critical factor, by all health care professionals using information and communications technologies for the exchange of valid information for diagnosis, treatment and prevention of disease and injuries, research and evaluation, and for the continuing education of health care providers, all in the interests of advancing the health of individuals and their communities.”

Telemedicine is the delivery of health care services, where distance is a critical factor, by all health care professionals using information and communications technologies for the exchange of valid information for diagnosis, treatment and prevention of disease and injuries, research and evaluation, and for the continuing education of health care providers, all in the interests of advancing the health of individuals and their communities.”

Telemedicine is the delivery of health care services, where distance is a critical factor, by all health care professionals using information and communications technologies for the exchange of valid information for diagnosis, treatment and prevention of disease and injuries, research and evaluation, and for the continuing education of health care providers, all in the interests of advancing the health of individuals and their communities.”

Telemedicine is the delivery of health care services, where distance is a critical factor, by all health care professionals using information and communications technologies for the exchange of valid information for diagnosis, treatment and prevention of disease and injuries, research and evaluation, and for the continuing education of health care providers, all in the interests of advancing the health of individuals and their communities.”

Telemedicine is the delivery of health care services, where distance is a critical factor, by all health care professionals using information and communications technologies for the exchange of valid information for diagnosis, treatment and prevention of disease and injuries, research and evaluation, and for the continuing education of health care providers, all in the interests of advancing the health of individuals and their communities.

Telemedicine is the delivery of health care services, where distance is a critical factor, by all health care professionals using information and communications technologies for the exchange of valid information for diagnosis, treatment and prevention of disease and injuries, research and evaluation, and for the continuing education of health care providers, all in the interests of advancing the health of individuals and their communities.

Telemedicine can be determined as an integration of several components including information and communication technologies, hardware and software technologies and medical services operating together in order to provide required features or services to users

Telemedicine can be determined as an integration of several components including information and communication technologies, hardware and software  technologies and medical services operating together in order to provide required features or services to users

Telemedicine can be determined as an integration of several components including information and communication technologies, hardware and software  technologies and medical services operating together in order to provide required features or services to users  as shown in Fig 1. underlying technologies are seen as a black box to the users and they are responsible for facilitating processes of each proposed service

EDUCATION AND PRACTICE Fundamentals "" Introduction to the practice of telemedicine John Craig* and Victor Patterson* Department of Neurology, Royal Victoria Hospital, Belfast, UK; Centre for Online Health, University of Queensland, Brisbane, Australia

Summary

Telemedicine is the delivery of health care and the exchange of health-care information across distances. It is not a technology or a separate or new branch of medicine. Telemedicine episodes may be classi?ed on the basis of: (1) the interaction between the client and the expert (i.e. realtime or prerecorded), and (2) the type of information being transmitted (e.g. text, audio, video). Much of the telemedicine which is now practised is performed in industrialized countries, such as the USA, but there is increasing interest in the use of telemedicine in developing countries. There are basically two conditions under which telemedicine should be considered: (1) when there is no alternative (e.g. in emergencies in remote environments), and (2) when it is better than existing conventional services (e.g. teleradiology for rural hospitals). For example, telemedicine can be expected to improve equity of access to health care, the quality of that care, and the eficiency by which it is delivered.

Research in telemedicine increased steadily in the late 1990s, although the quality of the research could be improved – there have been few randomized controlled trials to date. Introduction One of the great challenges facing humankind in the 21st century is to make high-quality health care available to all. Such a vision has been expressed by the World Health Organization (WHO) in its health-for-all strategy in the 21st century.

1
Realizing this vision will be dificult, perhaps impossible, because of the burdens imposed on a growing world population by old and new diseases, rising expectations for health, and socioeconomic conditions that have, if anything, increased disparities in health status between and within countries. Traditionally, part of the dificulty in achieving equitable access to health care has been that the provider and the recipient must be present in the same place and at the same time. Recent advances in information and communication technologies, however, have created unprecedented opportunities for overcoming this by increasing the number of ways that health care can be delivered. This applies both to developing countries with weak or unstable economies and to industrialized countries. The possibilities for using information and communication technologies to improve health-care delivery (‘health telematics’) are increasingly being recognized. The WHO has stated that with regard to its health-for-all strategy it recommends that the WHO and its member states should: integrate the appropriate use of health telematics in
the overall policy and strategy for the attainment of health for all in the 21st century, thus ful?lling the vision of a world in which the benefits of science, technology and public health development are made equitably available to all people everywhere.

2
Such a commitment to improve health-care delivery, by utilizing information and telecommunications technologies, is also being considered by those with the technical means to do so, for example, the participants in various European Commission projects. At the national and subnational level, there is also evidence of governmental interest in the benefits that these technologies might bring to health care. For example, in the UK, information technology including telemedicine is at the heart of the government’s strategy to modernize and improve the NHS.
3
Telemedicine, the area where medicine and infor- mation and telecommunications technology meet, is probably the part of this revolution that could have the greatest impact on healthcare deliBased on service, the market is fragmented into Tele-consulting, Tele-monitoring, and Tele-education. The Tele-consulting segment generated more than 45% revenue in 2020. The market is expected to grow at a significant rate during the forecast period. As it permits patients to have appointments with experts at any instance of time, without any waitingBased on drug type, the market is bifurcated into over the counter (OTC) drugs, prescribed drugs, and others. The over the counter (OTC) drugs segment grabbed the major market in 2020 as OTC refers to a class of medication that can be sold without the need for a prescription and anyone can easily buy medicines with just a click. Moreover, according to Statista, the total sales value of over-the-counter (OTC) drugs in Great Britain amounted to 3.65 billion USD in 2020.

Based on types, the market is bifurcated into biopreservation media, biospecimen equipment, freezers, cryogenic storage systems, thawing equipment, and refrigerators. The biospecimen equipment segment grabbed the major market in 2020, owing to the increased investments from private and public organizations for research and development of cell and gene therapies and increasing acceptance of refrigerators, and biological freezers for the preservation of biological specimens.

Based on biospecimen, the market is bifurcated into human tissue samples, organs, stem cells, and others. The stem cells segment ruled the major market and accounted for the maximum share in 2020, credited to the augmenting awareness of people about conserving cord blood stem cells of newborns to treat chronic diseases like cancer and others.

Based on application, the market is bifurcated into therapeutic applications, research applications, clinical trials, and others. The therapeutic applications segment grabbed the major market in 2020. The highest growth of this segment is accredited due to the advancements in the fields of regenerative medicine, personalized medicine, and biobanking. 

Based on end-user, the market is bifurcated into biobanks, gene banks, hospitals, and others. The biobanks segment dominated the market in 2020, owing to the increasing demand for conserving biospecimens, tissues, organs, and stem cells for various research purposes. 

For a better understanding of the market adoption of the biopreservation market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for biopreservation and generated maximum revenue in 2020 owing to the high government funding, robust personal healthcare spending, developed awareness programs, rapid acceptance of new analytical techniques, and the presence of skilled professionals and physicians. 

Some of the major players operating in the market include Thermo Fisher Scientific Inc., Merck KGaA, ThermoGenesis Holdings, Inc., Bio-Techne Corporation, BioLife Solutions, Inc., Exact Sciences Corporation, Princeton CryoTech, Inc., Stemcell Technologies, Inc., OPS Diagnostics, AMS Biotechnology, etc. Several M&As along with partnerships have been undertaken by these players to develop the biopreservation market. 

Biopreservation provides a broad range of therapeutic and industrial applications for developing cell-based technologies. It is used in numerous healthcare facilities to conserve the functionality and integrity of clinical trial materials such as eggs, sperm, embryos, and other biological materials. Biopreservation preserves the purity and sustainability of biospecimens while also extending their shelf life. Biobanking, a form of biopreservation, is commonly used in medical research related to precision medicine and genomics research. The basic role of biobanks is to collect, process, and store samples and associated records. For instance, in June 2021, Biodesix Inc. a lung cancer diagnostic solutions company, announced a strategic partnership with Datavant to help protect, match, and share health data. Through this partnership, Biodesix anonymizes the lung cancer portion of its expansive sample and data biobank using Datavant’s proprietary tokenization process and connects it to multiple real-world data sets while compliantly and securely protecting patient privacy.

Further, the progression of regenerative medicine for treating and controlling various chronic diseases such as cancer, heart failure, diabetes, including Covid-19 are adding pace to the growth of the biopreservation market. According to the American Cancer Society, in 2020, there were approximately 89,500 cancer cases diagnosed, and about 9,270 cancer deaths in adolescents and young adults aged between 15 to 39 years in the US were recorded.  Hence, regenerative medicine and personalized medicine are expected to witness healthy growth in the future contributing to the overall growth of biopreservation market. Due to government-imposed lockdowns to prevent the spreading of Covid-19, the global biopreservation market has seen a small decline in the short term. Because of the pandemic, the worldwide supply chain stopped operating, which impacted the market. However, in the mid of the pandemic, there has been a rising demand for the preservation of plasmas, bodily fluids, tissues, and organs. Thus, resulted in the positive growth for biopreservation services. The market would remain bullish in the upcoming year. For instance, in March 2020, Columbia University Vagelos College of Physicians and Surgeons, U.S., in partnership with New York-Presbyterian Hospital, established a COVID-19 Biobank as a centralized resource to collect, store, and disseminate biological specimens and clinical data for researchers at Columbia University and elsewhere.

Thermo Fisher Scientific Inc., Merck KGaA, ThermoGenesis Holdings, Inc., Bio-Techne Corporation, BioLife Solutions, Inc., Exact Sciences Corporation, Princeton CryoTech, Inc., Stemcell Technologies, Inc., OPS Diagnostics, AMS Biotechnology are some of the prominent players operating in the biopreservation market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products.

Insights Presented in the Report

“Amongst Type, Biospecimen Equipment segment holds the major share”

Based on types, the market is bifurcated into biopreservation media, biospecimen equipment, freezers, cryogenic storage systems, thawing equipment, and refrigerators. The biospecimen equipment segment grabbed the major market in 2020, owing to increased investments from private and public organizations for research and development of cell and gene therapies and increasing acceptance of refrigerators, and biological freezers for the preservation of biological specimens.

“Amongst Biospecimen, Stem Cells segment is anticipated to grow at the highest CAGR during the analyzed period” 

Based on biospecimen, the market is bifurcated into human tissue samples, organs, stem cells, and others. The stem cells segment dominated the market in 2020 due to the augmenting awareness of people about conserving cord blood stem cells of newborns to treat chronic diseases like cancer and others.

“Amongst Application, Therapeutic Applications segment holds the major share”

Based on application, the market is bifurcated into therapeutic applications, research applications, clinical trials, and others. The therapeutic applications segment dominated the market in 2020. The highest growth of the segment can be accredited to the advancements in the fields of regenerative medicine, personalized medicine, and biobanking. 

“Amongst End-User, Biobank segment is anticipated to grow at the highest CAGR during the analyzed period” 

Based on end-user, the market is bifurcated into biobanks, gene banks, hospitals, and others. The biobanks segment accounted for major revenue share in 2020, due to the increasing demand for conserving biospecimens, tissues, organs, and stem cells for various research purposes. 

“North America signifies one of the largest markets of Biopreservation market”

For a better understanding of the market dynamics of the Biopreservation market, a detailed analysis was conducted for different regions across the globe including North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), Rest of World. North America constitutes a major market for Biopreservation and generated maximum revenue in 2020 owing to the high government funding, robust personal healthcare spending, developed awareness programs, rapid acceptance of new analytical techniques, and the presence of skilled professionals and physicians.

Reasons to buy this report:

  • The study includes market sizing and forecasting analysis validated by authenticated key industry experts
  • The report presents a quick review of overall industry performance at one glance
  • The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
  • Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
  • The study comprehensively covers the market across different segments
  • Deep dive regional level analysis of the industry

Customization Options:

The Biopreservation Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

Companies Covered

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • ThermoGenesis Holdings Inc.
  • Bio-Techne Corporation
  • BioLife Solutions Inc.
  • Exact Sciences Corporation
  • Princeton CryoTech Inc.
  • Stemcell Technologies, Inc.
  • OPS Diagnostics
  • AMS Biotechnology

Have query on this report?

Make an Enquiry

Table of Content

1 MARKET INTRODUCTION
1.1 Market Definitions
1.2 Objective of the Study
1.3 Limitation
1.4 Stake Holders
1.5 Currency Used in Report
1.6 Scope of the Global Biopreservation Market Study

2 RESEARCH METHODOLOGY OR ASSUMPTION
2.1 Research Methodology for the Global Biopreservation Market
2.1.1 Main Objective of the Global Biopreservation Market

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 TOP START-UPs UNDER BIOPRESERVATION INDUSTRY

6 COVID-19 IMPACT

7 GLOBAL BIOPRESERVATION MARKET REVENUE

8 MARKET INSIGHTS BY TYPE

8.1 Biopreservation Media
8.2 Biospecimen Equipment
8.3 Freezers
8.4 Cryogenic Storage Systems
8.5 Thawing Equipment
8.6 Refrigerators

9 MARKET INSIGHTS BY BIOSPECIMEN
9.1 Human Tissue Samples
9.2 Organs
9.3 Stem Cells
9.4 Others

10 MARKET INSIGHTS BY APPLICATION
10.1 Therapeutic Applications
10.2 Research Applications
10.3 Clinical Trials
10.4 Others

11 MARKET INSIGHTS BY END-USER
11.1 Biobanks
11.2 Gene Banks
11.3 Hospitals
11.4 Others

12 MARKET INSIGHTS BY REGION
12.1 NORTH AMERICA BIOPRESERVATION MARKET
12.1.1 United States
12.1.2 Canada
12.1.3 Rest of North America
12.2 EUROPE BIOPRESERVATION MARKET
12.2.1 Germany
12.2.2 France
12.2.3 United Kingdom
12.2.4 Spain
12.2.5 Italy
12.2.6 Rest of Europe
12.3 ASIA PACIFIC BIOPRESERVATION MARKET
12.3.1 China
12.3.2 Japan
12.3.3 India
12.3.4 Australia
12.3.6 Rest of Asia Pacific
12.4 REST OF THE WORLD BIOPRESERVATION MARKET

13 BIOPRESERVATION MARKET DYNAMICS
13.1 Market Drivers
13.2 Market Challenges
13.3 Impact Analysis

14 BIOPRESERVATION MARKET OPPORTUNITIES

15 BIOPRESERVATION MARKET TRENDS & INSIGHTS

16 LEGAL & REGULATORY FRAMEWORK

17 DEMAND AND SUPPLY SIDE ANALYSIS

17.1 Demand Side Analysis
17.2 Supply Side Analysis
17.2.1 Top Product Launches
17.2.2 Top Business Partnerships
17.2.3 Top Merger & Acquisitions

18 VALUE CHAIN ANALYSIS

19 COMPETITIVE SCENARIO

19.1 Porter’s Five forces analysis
19.1.1 Bargaining power of Supplier
19.1.2 Bargaining power of Buyer
19.1.3 Industry Rivalry
19.1.4 Availability of Substitute
19.1.5 Threat of new Entrants
19.2 Market Share, by Company

20 COMPANY PROFILED
20.1 Thermo Fisher Scientific Inc.
20.1.1 Key Facts
20.1.2 Business Description
20.1.3 Key Product/Services Offerings
20.1.4 Growth Strategy
20.1.5 SWOT Analysis
20.1.6 Key Financials
20.1.6.1 Revenue Split
20.1.6.2 Financial Overview of Thermo Fisher Scientific Inc.
20.1.7 Recent Developments
20.1.7.1 Product Launch
20.1.7.2 Partnerships
20.1.7.3 Business Expansion and Investments
20.1.7.4 Merger and Acquisition
20.2 Merck KGaA
20.3 ThermoGenesis Holdings, Inc.
20.4 Bio-Techne Corporation
20.5 BioLife Solutions, Inc.
20.6 Exact Sciences Corporation
20.7 Princeton CryoTech, Inc.
20.8 Stemcell Technologies, Inc.
20.9 OPS Diagnostics
20.10 AMS Biotechnology

21 DISCLAIMER

Success Stories

Our Clients